---
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/265191156.md"
description: "The Chief Financial Officer of Gilead Sciences stated that the company will continue to actively pursue business expansion, including licensing collaborations and mergers and acquisitions"
datetime: "2025-11-10T16:35:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/265191156.md)
  - [en](https://longbridge.com/en/news/265191156.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/265191156.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/265191156.md) | [English](https://longbridge.com/en/news/265191156.md)


# 

Gilead Sciences' Chief Financial Officer stated that the company will continue to actively pursue business expansion, including licensing collaborations and mergers and acquisitions

### 相關股票

- [Gilead Sciences (GILD.US)](https://longbridge.com/zh-HK/quote/GILD.US.md)

## 相關資訊與研究

- [Gilead Sciences Inc Stock (GILD) Moved Up by 3.62% on Mar 31: A Full Analysis](https://longbridge.com/zh-HK/news/281203982.md)
- [Galapagos, Gilead Enter Binding Agreement On Ouro Medicines Acquisition](https://longbridge.com/zh-HK/news/281128280.md)
- [BMS, Novartis, Gilead, Iovance dinged in CBER untitled letters](https://longbridge.com/zh-HK/news/281059389.md)
- [Gilead Powers Up Its Inflammation Pipeline With Over $1.5 Billion Acquisition](https://longbridge.com/zh-HK/news/280356780.md)
- [Gilead acquires first TCE asset with $2.2bn Ouro Medicines buyout](https://longbridge.com/zh-HK/news/280351103.md)